RKIP has been reported to have direct and indirect effects on CTL-mediated anti-tumor responses via the regulation of pathways involved in CD8+ T cell survival, proliferation, differentiation, and cytotoxic activities [182]. The gene discussed is PEBP1; the disease is neoplasm.